Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer
- 1 April 2020
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 149, 45-57
Abstract
No abstract availableKeywords
Funding Information
- The Scientific and Technological Research Council of Turkey (215M759, 113M259)
This publication has 62 references indexed in Scilit:
- Biological hydrogels as selective diffusion barriersTrends in Cell Biology, 2011
- Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucusBiomaterials, 2011
- Surface Tension Gradient Driven Spreading on Aqueous Mucin Solutions: A Possible Route to Enhanced Pulmonary Drug DeliveryMolecular Pharmaceutics, 2011
- Disruption of the Mucus Barrier by Topically Applied Exogenous ParticlesMolecular Pharmaceutics, 2010
- Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriersJournal of Controlled Release, 2010
- Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivoBiomaterials, 2010
- The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticlesBiomaterials, 2009
- Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissuesAdvanced Drug Delivery Reviews, 2009
- Controlled Surface Modification with Poly(ethylene)glycol Enhances Diffusion of PLGA Nanoparticles in Human Cervical MucusMolecular Pharmaceutics, 2008
- Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorderDrug Discovery Today: Disease Mechanisms, 2007